Press release
Neurodegenerative Diseases Drugs Market Latest Trends, Revenue Growth Rate And Application Scope
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/neurodegenerative-diseases-drugs-market-100661
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
This Report Answers the Following Questions:
Which strategies are being implemented by companies to boost sales of neurodegenerative diseases drugs?
What are the market drivers, trends, challenges, and opportunities?
Which segment is anticipated to dominate the market in terms of share?
Which region would lead by generating the highest revenue in the near future?
Drivers & Restraints-
Rising Prevalence of Alzheimer's Disease to Aid Growth
Neurodegenerative diseases refer to all those disease that severely affect the neurons of the brain. One of the most prevalent neurodegenerative diseases is Alzheimer's. In the U.S. alone, in 2019, approximately 5.8 million cases of Alzheimer's dementia were recorded. Others include multiple system atrophy, spinal muscular atrophy, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, and Parkinson's disease. Besides, numerous companies are investing hefty amounts of money in research and development activities, which, in turn, is augmenting the clinical research on neurodegenerative diseases and their possible cure. These factors are expected to propel the neurodegenerative diseases drugs market in the near future.
Segment-
Multiple Sclerosis Segment to Dominate Backed by Rising Number of New Product Launches
In terms of disease indication, the market is divided into spinal muscular atrophy (SMA), Alzheimer's disease, Parkinson's disease, multiple sclerosis, and others. Out of these, the multiple sclerosis segment held 66.1% neurodegenerative diseases drugs marketshare in 2018 and is set to dominate throughout the forthcoming years. This growth is attributable to the increasing number of novel product launches, favourable government recommendations, and expensive nature of drugs.
Regional Analysis-
North America to Lead Owing to Rising Investment in R&D Activities
North America generated USD 18,174.6 million revenue in 2018 and is likely to lead the market in the coming years. This growth is attributable to the positive health reimbursement policies, rising investment in research and development, high pricing, and increasing demand forneurodegenerative diseases drugs. Europe, on the other hand, is set to showcase considerable growth in the near future on account of the FDA approval for marketing and distributing SPINRAZA, as well as active support of the government. In Asia Pacific, the market would grow steadily and thus, the region is set to showcase the highest CAGR. It would occur because the increasing prevalence of diseases such as Parkinson's and Alzheimer's. Apart from that, the rising geriatric population and higher incidence of neurodegenerative diseases would drive growth of the market in this region.
Competitive Landscape-
Key Players Focus on Strategic Partnerships to Launch New Drugs
Several companies present in the market are actively participating in extensive research and development activities to introduce unique products. The governments of numerous countries are also providing grants to the research institutes to discover new products to cater to the growing demand from the consumers. Additionally, many other companies are adopting the strategy of collaborations and partnerships to co-promote or co-develop new drugs. Below are two of the key industry developments:
March 2019: Novartis announced that it received the FDA approval for Mayzent® (siponimod). It is considered to be the first treatment option approved for those suffering from secondary progressive multiple sclerosis (SPMS). It is meant for patients belonging to the age group of 15 years and above.
January 2018: Biogen Japan Ltd. and Eisai Co., Ltd. started co-promoting AVONEX®, TYSABRI®, and TECFIDERA®. They are manufactured by Biogen Japan for treating multiple sclerosis. They will provide information regarding the usage of these drugs at healthcare facilities.
Fortune Business Insights™ presents a list of all the neurodegenerative diseases drugs manufacturers operating in the market. They are as follows:
Novartis AG
Biogen
Lundbeck A/S
Pfizer, Inc.
Mitsubishi Tanabe Pharma Corporation
Hoffmann-La Roche Ltd.
Orion Pharma
Merck & Co., Inc.
UCB S.A.
Teva Pharmaceutical Industries Ltd.
Sanofi
ACADIA Pharmaceuticals Inc.
Other key market players
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurodegenerative Diseases Drugs Market Latest Trends, Revenue Growth Rate And Application Scope here
News-ID: 2553882 • Views: …
More Releases from Fortune Business Insights Pvt. Ltd.
Luxury Goods Market Size Report, Trends, Overview, Outlook & Future Growth By 20 …
The global luxury goods market size was valued at USD 272.74 billion in 2022. The market is anticipated to grow from USD 284.00 billion in 2023 to USD 392.40 billion by 2030, exhibiting a CAGR of 4.7% during the forecast period.
Luxury products signify the status symbol of an individual. Businesses focus on high-income populations with visually appealing designs and technology-integrated products. For instance, NFC-installed chips in jewelry; a product called…
With 17.2% CAGR, Smart Glass market Market to Hit USD 15,788.0 Million by 2022-2 …
The global smart glass market size is anticipated to reach USD 15,788.0 million by 2027, owing to the rise in the use of smart glass for different applications such as aerospace, marine, architectural, and automotive.
Smart glass or switchable glass is glazing or a glass with altered transmission properties as and when heat, light, or voltage is applied. They are capable of changing their appearance from opaque to translucent to transparent…
Non-alcoholic Beverages Market Segmentation& Analysis, Industry Growth Forecast …
According to Fortune Business Insights ™, the global non-alcoholic beverages market size is anticipated to rise significantly on account of the current trend of health and fitness and the rising inclination towards healthy beverages. The value of this market was USD 919.13 billion in 2019 and is expected to rise at a CAGR of 8.20% between 2020 to 2027 to reach USD 1,257.77 billion by the end of 2027.
List of…
Intravenous Iron Drugs Market 2022: Global Technology, Segmentation, Growth, Dev …
Global Intravenous Iron Drugs Market Size research report 2022 offers an in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. The demand for refractive surgeries is anticipated to increase, attributed to the rise in the aging population and excessive use of digital devices, which has increased the screen time of the world population due to the…
More Releases for Disease
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,…
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
